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httpcense.Abstract Respiratory muscle dysfunction is a cardinal feature of acute and chronic respiratory
failure in COPD. Diaphragm and accessory inspiratory muscles face increased load due to increased
lung resistance and elastance, as well as increased ventilatory demand.
Aim of the work: The objective of this work is to measure maximal inspiratory pressure (MIP)
and maximal expiratory pressure (MEP) in stable COPD patients and to correlate it with degree of
airway obstruction and functional disability.
Subjects, methods and result: Forty known COPD male patients were enrolled in this study with
mean age 56.8 ± 7.7. Spirometry was done for all patients with mean FEV1 39.5 ± 15.1%, mean
FVC 59.5 ± 19.2%, mean FEV1/FVC 52.9 ± 10.3%. Maximum inspiratory and expiratory pres-
sures were done with mean 43.6 ± 26.9% and 46.8 ± 26% respectively. As regards 6 min walk dis-
tance, its mean was 131.41 ± 41.73 m. A quantiﬁcation of dyspnea using the Modiﬁed Medical
Research Council Scale (MRC) was done. The results of the present study showed: a highly signif-
icant positive statistical correlation between MIP, MEP and 6 min walk distance, also highly signif-
icant negative statistical correlation between MIP, MEP and MRC dyspnea scale. We note ary pressure; MEP, maximal
lk distance; COPD, chronic
lmonary function test; FEV1,
, forced vital capacity
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330 M. Khalil et al.signiﬁcant positive correlation between MIP and each of PaO2 and SaO2, while MEP has a signif-
icant correlation with SaO2, also a highly signiﬁcant negative statistical correlation between MIP,
MEP and PaCO2.
Conclusion: A highly signiﬁcant positive statistical correlation between MIP, MEP and 6 min
walk distance and a highly signiﬁcant negative statistical correlation between MIP, MEP and sub-
jective dyspnea evaluated by MRC dyspnea scale were found.
ª 2014 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. Open access under CC BY-NC-ND license.Introduction
Chronic obstructive pulmonary disease (COPD) is a prevent-
able and treatable disease with some signiﬁcant extra pulmon-
ary effects that may contribute to the severity in individual
patients. Its pulmonary component is characterized by airﬂow
limitation that is not fully reversible. The airﬂow limitation is
usually progressive and associated with an abnormal inﬂam-
matory response of the lung to noxious particles or gases [1].
Respiratory, and particularly inspiratory, muscle function
is altered in COPD. Many of these alterations are secondary
to a mechanical disadvantage related to hyperinﬂation. Other
factors, including corticosteroid therapy and nutritional deple-
tion, are also deleterious to muscle function. Moreover, the
imbalance between respiratory muscle function and load is
an important determinant of dyspnea and hypercapnia. Be-
cause much of the lung and airway derangements are irrevers-
ible in COPD, the respiratory muscles appear to be an
attractive target for therapeutic interventions [2].
Maximal inspiratory pressure (MIP) is the maximum nega-
tive pressure that can be generated from one inspiratory effort
starting from functional residual capacity (FRC) or residual
volume (RV). Maximal expiratory pressure (MEP) measures
the maximum positive pressure that can be generated from
one expiratory effort starting from total lung capacity (TLC)
or FRC. Unlike inspiratory muscles, expiratory muscles
(abdominal and thoracic muscles) reach their optimal force–
length relationship at high pulmonary volumes [3].
Respiratory muscle dysfunction is a cardinal feature of
acute and chronic respiratory failure in COPD. Diaphragm
and accessory inspiratory muscles face increased load due to
increased lung resistance and elastance, as well as increased
ventilatory demand [4].
Measurement of the maximum static inspiratory pressure
that a subject can generate at the mouth (PImax) or the max-
imum static expiratory pressure (PEmax) is a simple way to
gauge inspiratory and expiratory muscle strength. When respi-
ratory muscle weakness occurs, the PImax can be more sensi-
tive than the VC because the relationship between VC and
PImax is curvilinear, so that decreases in respiratory muscle
strength occur before decreases in lung volume can be identi-
ﬁed [5].
Aim of the work
The objective of this work is to measure maximal inspiratory
pressure (MIP) and maximal expiratory pressure (MEP) in sta-
ble COPD patients and to correlate MIP and MEP values with
degree of airway obstruction and functional disability.Subjects and methods
The present study was conducted upon forty known COPD
patients according to GOLD 2010 guidelines at Ain Shams
University Hospital in the period between August 2011 and
March 2012.
For all patients the following were done
 Full history taking.
 Physical examination.
 Chest X-ray.
 Spirometric pulmonary function.
 Maximal inspiratory pressure and maximal expiratory
pressure.
 Arterial blood gases.
 Six minute walking test according to ATS standards [6].
Subjective dyspnea scale
A quantiﬁcation of dyspnea using the Modiﬁed Medical Re-
search Council Scale (MRC) is indicated since it predicts qual-
ity of life and survival (Functional Dyspnea):
Exclusion criteria
 Patients with primary muscular or neuromuscular diseases.
 Patients with clinically signiﬁcant co morbidities those are
likely to affect test results.
 COPD patients in exacerbation.
 NB: Spirometry, MIP and MEP were done using Master
Screen PFT with built in program for measuring MIP and
MEP.
Measurement of MIP and MEP
We can measure MIP and MEP according to [7].
Subject preparations
The subjects were instructed not to engage in heavy exercise
immediately before testing.
Equipment
System description. We use a pulmonary function testing
instrument with software and hardware adaptations that allow
for the measurement of respiratory muscle pressures.
Table 1 Correlation between MIP and each of FEV1%,
FVC%, FEV1/FVC%, 6MWD, PaO2, PaCO2, SaO2% and
dyspnea scale.
Variable MIP%
r-Value P-Value Sig.
FEV1% 0.145 0.391 NS
FVC% 0.159 0.346 NS
FEV1/FVC% 0.86 0.615 NS
6MWD (m) 0.546 0.0001 HS
PaO2 (mmHg) 0.339 0.040 S
PaCO2 (mmHg) 0.492 0.002 HS
SaO2% 0.381 0.020 S
Dyspnea scale 0.954 0.0001 HS
This table shows that there was:
No signiﬁcant statistical correlation between MIP and each of
FEV1%, FVC% and FEV1/FVC%.
Highly signiﬁcant positive statistical correlation between MIP and
6MWD.
Signiﬁcant positive correlation between MIP and each of PaO2 and
SaO2%.
Highly signiﬁcant negative statistical correlation between MIP and
PaCO2.
Highly signiﬁcant negative statistical correlation between MIP and
dyspnea scale.
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 The maneuver was explained and demonstrated to the sub-
jects using a spare mouthpiece.
 The subjects were instructed to sit upright.
 The subjects were instructed to keep a tight lip seal and to
give maximum effort.
 A tight-ﬁtting nose clip was attached to the patient’s nose to
prevent leakage.
Steps.
(1) A tight-ﬁtting disposable rubber mouth piece was placed
ﬁrmly onto the mouth piece adapter.
(2) MIP: from tidal breathing the patient slowly exhales as
deeply as possible. During expiration the measurement
is started manually. The shutter will be set as soon as
the patient starts to breathe in. Now the patient is asked
to inspire as fast and as powerful as possible against the
shutter. The maximal inspiratory pressure will be reached
after about 0.5–1 s. The shutter opens automatically.
(3) MEP: from tidal breathing the patient slowly breathes in
as deeply as possible. The shutter will be closed with
expiration onset. Now the patient is asked to expire as
fast and as powerful as possible against the shutter.
The shutter will be opened automatically.
(4) Three trials were obtained.
(5) The subjects were allowed to rest for 30 to 60 s between
trials.
Reporting results. The most negative values of MIP and MEP
were reported in (k pa).
Statistical methodology
Data management and analysis:
The collected data were revised, coded, tabulated and intro-
duced to a PC using Statistical package for Social Science
(SPSS 15.0.1 for windows; SPSS Inc, Chicago, IL, 2001). Data
were presented and suitable analysis was done according to the
type of data obtained for each parameter.
Descriptive statistics:
(1) Mean, Standard deviation (±SD) and range for para-
metric numerical data
(2) Frequency and percentage of non-numerical data.
Analytical statistics:
(1) Correlation analysis (using Pearson’s method): To assess
the strength of association between two quantitative
variables. The correlation coefﬁcient denoted symboli-
cally ‘‘r’’ deﬁnes the strength and direction of the linear
relationship between two variables.
(2) ANOVA test was used to assess the statistical signiﬁ-
cance of the difference between more than two study
group means.
P-value: level of signiﬁcance: P> 0.05: Non signiﬁcant
(NS).P< 0.05: Signiﬁcant (S). P< 0.01: Highly signiﬁcant (HS)
Results
Forty known COPD male patients were enrolled in this study
with mean age 56.8 ± 7.7 and smoking index mean 30 ± 10.1.
Spirometry was done for all patients with mean FEV1
39.5 ± 15.1%, mean FVC 59.5 ± 19.2%, mean FEV1/FVC
52.9 ± 10.3%. Maximum inspiratory & expiratory pressures
were determined with mean 43.6 ± 26.9% and 46.8 ± 26%
respectively mean PH 7.40 ± 0.03, mean PaCO2 40.09 ±
4.23 mmHg, mean PaO2 71.89 ± 9.35 mmHg, mean SaO2
93.43 ± 2.80%. As regards 6 min walk distance, its mean
was 131.41 + 41.73 m.
 Correlation between MIP and each of FEV1%, FVC%,
FEV1/FVC%, 6MWD, PaO2, PaCO2, SaO2% and dyspnea
scale is shown in Table 1. There was no signiﬁcant statistical
correlation between MIP and each of FEV1%, FVC% and
FEV1/FVC% but highly signiﬁcant positive statistical cor-
relation between MIP and 6MWD, signiﬁcant positive cor-
relation between MIP and each of PaO2 and SaO2%, highly
signiﬁcant negative statistical correlation between MIP and
PaCO2 and highly signiﬁcant negative statistical correlation
between MIP and dyspnea scale.
 There was a signiﬁcant positive correlation between maxi-
mal inspiratory pressure and PaO2 as shown in Fig. 1,
and a highly signiﬁcant negative statistical correlation
between maximal inspiratory pressure and PaCO2 as shown
in Fig. 2.
 There was a highly signiﬁcant negative statistical correla-
tion between maximal inspiratory pressure and dyspnea
scale as shown in Fig. 3.
 Correlations between MEP and each of FEV1%, FVC%,
FEV1/FVC%, 6MWD, PaO2, PaCO2 and SaO2% (Table 2).
There was no signiﬁcant statistical correlation between
PaO2 (mmHg)
1009080706050
100.0
80.0
60.0
40.0
20.0
0.0
M
ax
im
um
 in
sp
ir
at
or
y 
pr
es
su
re
 %
Figure 1 Correlation between maximal inspiratory pressure and PaO2.
Table 2 Correlations between MEP and each of FEV1%,
FVC%, FEV1/FVC%, 6MWD, PaO2, PaCO2 and SaO2%.
Variable MEP%
r-Value P-Value Sig.
FEV1% 0.168 0.321 NS
FVC% 0.234 0.164 NS
FEV1/FVC% 0.46 0.785 NS
6MWD (m) 0.523 0.001 HS
PaO2 (mmHg) 0.310 0.062 NS
PaCO2 (mmHg) 0.459 0.004 HS
SaO2% 0.398 0.015 S
Dyspnea scale 0.905 0.0001 HS
This table shows that there was:
No signiﬁcant statistical correlation between MEP and each of
FEV1%, FVC%, FEV1/FVC% and PaO2.
Highly signiﬁcant positive statistical correlation between MEP and
6MWD.
Signiﬁcant positive correlation between MEP and SaO2%.
Highly signiﬁcant negative statistical correlation between MEP and
PaCO2.
Highly signiﬁcant negative statistical correlation between MEP and
dyspnea scale.
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Figure 2 Correlation between maximal inspiratory pressure and
PaCO2.
Dyspnea scale
5.004.003.002.001.00
100.0
80.0
60.0
40.0
20.0
0.0
M
ax
im
um
 in
sp
ir
at
or
y 
pr
es
su
re
%
Figure 3 Correlation between maximal inspiratory pressure and
dyspnea scale.
332 M. Khalil et al.MEP and each of FEV1%, FVC%, FEV1/FVC% and PaO2
but highly signiﬁcant positive statistical correlation between
MEP and 6MWD also signiﬁcant positive correlation
between MEP and SaO2%, highly signiﬁcant negativestatistical correlation between MEP and PaCO2 and highly
signiﬁcant negative statistical correlation between MEP and
dyspnea scale.
 There is a highly signiﬁcant positive statistical correlation
between maximal expiratory pressure and 6 min walk dis-
tance as shown in Fig. 4, and a highly signiﬁcant negative
statistical correlation between maximal expiratory pressure
and dyspnea scale as shown in Fig. 5.
 Table 3 shows that there was a highly signiﬁcant positive
correlation between FEV1% and each of PaO2 and
SaO2% but highly signiﬁcant negative statistical correlation
between FEV1% and PaCO2 and highly signiﬁcant positive
statistical correlation between FEV1% and 6MWD
 Table 4 shows that there was a highly signiﬁcant positive
statistical correlation between FVC% and 6 min walk
distance.
Table 3 Correlations between FEV1% and each of PaO2,
PaCO2, SaO2% and 6MWD.
Variable FEV1%
r-Value P-Value Sig.
PaO2 (mmHg) 0.675 0.000 HS
PaCO2 (mmHg) 0.610 0.000 HS
SaO2% 0.642 0.000 HS
6MWD (m) 0.506 0.001 HS
This table shows that there was:
Highly Signiﬁcant positive correlation between FEV1% and each of
PaO2 and SaO2%.
Highly signiﬁcant negative statistical correlation between FEV1%
and PaCO2.
Highly signiﬁcant positive statistical correlation between FEV1%
and 6MWD.Maximum expiratory pressure%
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Figure 4 Correlation between maximal expiratory pressure and
6 min walk distance.
Table 4 Correlations between FVC% and 6 min walk
distance.
Variable FVC%
r-value p-value Sig.
6MWD (m) 0.486 0.002 HS
This table shows that there was:
Highly signiﬁcant positive statistical correlation between FVC%
and 6 min walk distance.
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In the present study, it was found that there was no correlation
between maximal inspiratory and expiratory pressures with
spirometric pulmonary functions regarding FEV1%, FVC%
and FEV1/FVC%.
These correlations were studied before and disagree with
our results, Kabitz et al., (2007) [8]found a positive statistical
correlation between maximal inspiratory pressure and lung
function parameter (FEV1%) who conducted their study upon
stable COPD population compared to healthy, non-smoking
men as a control.
Also Terzano et al. [3]found a signiﬁcant positive correla-
tion between maximal inspiratory and expiratory pressures
with FEV1% and FVC%. This study was conducted upon pa-
tients with stable COPD and age-matched healthy subjects.
Moreover Nishimura et al. [9] and Heijdra et al. [10] found a
correlation between MIP and FEV1 in COPD patients. Also
a study done by Awad et al. [11] upon patients with a wide
range of the severity of the disease found a signiﬁcant positive
correlation between FEV1%, FVC% and FEV1/FVC% and
MIP.Dysp
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Figure 5 Correlation between maximal eWe can explain the differences in results between our study
and others; by the valuable observation by Rochester [12] who
suggested that the observed values of MIP in patients with
COPD should be compared with the values that normal
subjects would achieve at similar lung volumes. For normal
subjects was expected 80–90% of the predicted MIP at 60%
TLC. This means that MIP, after correction for lung volume,
was not lower than the values in normal subjects as was sug-
gested in previous studies. Also the current study was done
upon non homogenous group.
In this study, a signiﬁcant positive statistical correlation
was found between maximal inspiratory and expiratory pres-nea scale
5.004.003.00
xpiratory pressure and dyspnea scale.
334 M. Khalil et al.sures and 6 min walk distance values. In agreement with the
present study, Singer et al. [13] and Tudorache et al. [14] have
found the same statistical correlations.
In our study we correlate between MIP and MEP to MRC
dyspnea scale to deﬁne degree of patient’s disabilities. A nega-
tive signiﬁcant correlation was found between MIP and MEP
and MRC dyspnea scale grades, which is in agreement with
Gigliotti et al. [15].
The present study showed also a correlation between MIP
values with PaO2, PaCO2 and SaO2, while MEP correlates
only with PaCO2 and SaO2.
Kabitz et al. [8] found a signiﬁcant correlation between
MIP and PCO2. Another study by Heijdra et al. [10] found a
correlation between MIP and PaO2, PaCO2 and SaO2, while
MEP is not. Rochester and Braun [16] in a study done upon
32 COPD patients found a negative correlation between MIP
and PaCO2. Awad et al. [11] in their study found a signiﬁcant
correlation between arterial blood gases (PH, PaCO2, PaO2,
and SaO2%) and MIP.
Kabitz et al. [8] proposed that the PaCO2 will rise because
of reduced inspiratory muscle strength in COPD by two
mechanisms:
 First, reduced diaphragmatic contractility beginning in
early stages of the disease that is independent of
hyperinﬂation.
 Secondly, reduced diaphragmatic force generation due to
hyperinﬂation in severe disease stages only.
Heijdra et al. [10] found that the impairment in inspiratory
muscle strength causes micro-atelectasis resulting in a decrease
of PaO2 and the hypoxemia decreases the work of the respira-
tory muscles.
The current study showed a signiﬁcant positive correlation
between FEV1 and PaO2, and SaO2. Also a negative correla-
tion with PaCO2 .This is in agreement with Casanova et al.
[17] who found a positive correlation between FEV1 and each
of PaO2 and SaO2 also Fard and Zarezadeh [18] found a cor-
relation between FEV1 and PaO2, PaCO2.
The current study shows a signiﬁcant positive correlation
between FEV1 and 6 min walk distance. Also Casanova
et al. [17] showed a highly signiﬁcant positive correlation be-
tween FEV1 and 6 min walk distance in COPD patients and
Fujimoto et al. [19] too showed a positive correlation between
FEV1 and 6 min walk distance. Another study by Mak et al.
[20] upon 42 COPD patients found a positive correlation be-
tween FEV1 and FVC with 6 min walking distance.
Rate of desaturation after 6 min walk test was evaluated in
only 8 patients and showed non-signiﬁcant results and due to
small sample size we could not rely on these results which
needs further investigational studies
Conclusion
In the present study, it was found that:
 No signiﬁcant statistical correlation between MIP, MEP
and each of FEV1%, FVC% and FEV1/FVC%.
 Highly signiﬁcant positive statistical correlation between
MIP, MEP and 6 min walk distance. Highly signiﬁcant negative statistical correlation between
MIP, MEP and subjective dyspnea evaluated by MRC
dyspnea scale.
 Signiﬁcant positive correlation between MIP and each of
PaO2 and SaO2, while MEP has a signiﬁcant correlation
with SaO2 only.
 Highly signiﬁcant negative statistical correlation between
MIP, MEP and PaCO2.
 FEV1% shows a highly signiﬁcant correlation with 6 min
walk distance, PaO2, PaCO2 and SaO2.
 FVC% shows a highly signiﬁcant correlation with 6 min
walk distance.
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